JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Thyroid Cancer Epidemiology in Iran: a Time Trend Study
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Thyroid Cancer Epidemiology in Iran: a Time Trend Study
Safavi, Ali; Azizi, Fereidoun; Jafari, Rozita; Chaibakhsh, Samira; Safavi, Amir Ali;
  PDF(new window)
 Abstract
Background: Considering the rising incidence of thyroid cancer worldwide, the aim of our study was to investigate the temporal trends in the incidence of this cancer in a large population of Iranian patients. Materials and Methods: We used the Iran Cancer Data System (ICDS) Registry to assess the thyroid cancer trend from 2004 to 2010 with regard to different genders, age groups, and morphologies. To do this we analyzed the data of 10,913 new cases of thyroid cancer that occurred during these years. Results: The incidence rate (per one year) of thyroid cancer was 2.20 per 100,000 persons between 2004 and 2010 in Iran. Papillary thyroid cancer was the most common histology type, with an annual rate of 0.29 in Iran. The highest rate of prevalence in thyroid cancer was observed at the age of 45 years at the time of diagnosis. We found a female-to-male ratio of 2 in Iran. A significant decrease was detected in the trend of thyroid cancer in children <19y, which was not correlated to the trend of older patients. Conclusions: As expected, the trend of thyroid cancer increased over the 7 years, primarily contributed by papillary thyroid cancer. A rising pattern of incidence was seen in all the age groups except patients aged under 19 years.
 Keywords
Thyroid cancer;epidemiology;trend;papillary cancer;follicular cancer;cancer registry;
 Language
English
 Cited by
1.
Can We Rely on GLOBOCAN and GBD Cancer Estimates? Case Study of Lung Cancer Incidence and Mortality Rates and Trends in Iran,;;;

Asian Pacific Journal of Cancer Prevention, 2016. vol.17. 7, pp.3265-3269 crossref(new window)
1.
Analysis of Cancer Incidence and Mortality in Iran Using Joinpoint Regression Analysis, Iranian Red Crescent Medical Journal, 2016, 19, 3  crossref(new windwow)
2.
Hypermetabolic Thyroid Incidentaloma on Positron Emission Tomography: Review of Laboratory, Radiologic, and Pathologic Characteristics, Journal of Thyroid Research, 2017, 2017, 2042-0072, 1  crossref(new windwow)
3.
Circulating levels of PTEN and KLLN in papillary thyroid carcinoma: can they be considered as novel diagnostic biomarkers?, Endocrine, 2017, 57, 3, 428  crossref(new windwow)
 References
1.
Aceves C, Anguiano B, Delgado G (2013). The extrathyronine actions of iodine as antioxidant, apoptotic, and differentiation factor in various tissues. Thyroid, 23, 938-46. crossref(new window)

2.
Albores-Saavedra J, Henson DE, Glazer E, Schwartz AM (2007). Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype--papillary, follicular, and anaplastic: a morphological and epidemiological study. Endocr Pathol, 18, 1-7. crossref(new window)

3.
American Cancer Society 2009, Cancer facts and figures 2008,

4.
Aschebrook-Kilfoy B, Grogan RH, Ward MH, Kaplan E, Devesa SS (2013). Follicular thyroid cancer incidence patterns in the United States, 1980-2009. Thyroid, 23, 1015-21. crossref(new window)

5.
Aschebrook-Kilfoy B, Ward MH, Sabra MM, Devesa SS (2011). Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid, 21, 125-34. crossref(new window)

6.
Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS, Sturgeon C (2007). Extent of surgery affects survival for papillary thyroid cancer. Ann Surg, 246, 375-81. crossref(new window)

7.
Canadian cancer society's advisory committee on cancer statistics 2013, Canadian cancer statistics 2013 Toronto, Canadian cancer society.

8.
Chen AY, Jemal A, Ward EM (2009). Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer, 115, 3801-7. crossref(new window)

9.
Cossu A, Budroni M, Paliogiannis P, et al (2013). Epidemiology of thyroid cancer in an area of epidemic thyroid goiter. J Cancer Epidemiol, 2013, 584768.

10.
Dal ML, Bosetti C, La VC, Franceschi S (2009). Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control, 20, 75-86. crossref(new window)

11.
Davies L, Welch HG (2010). Thyroid cancer survival in the United States: observational data from 1973 to 2005. Arch Otolaryngol Head Neck Surg, 136, 440-4. crossref(new window)

12.
Dinets A, Hulchiy M, Sofiadis A, et al (2012). Clinical, genetic, and immunohistochemical characterization of 70 Ukrainian adult cases with post-chornobyl papillary thyroid carcinoma. Eur J Endocrinol, 166, 1049-60. crossref(new window)

13.
Du Y, Han LY, Li DD, et al (2013). Associations between XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms and risk of differentiated thyroid carcinoma: a meta-analysis. Asian Pac J Cancer Prev, 14, 5483-7. crossref(new window)

14.
El-Basmy A, Al-Mohannadi S, Al-Awadi A (2012). Some epidemiological measures of cancer in Kuwait: national cancer registry data from 2000-2009. Asian Pac J Cancer Prev, 13, 3113-8. crossref(new window)

15.
Eser S, Yakut C, Ozdemir R, et al (2010). Cancer incidence rates in Turkey in 2006: a detailed registry based estimation. Asian Pac J Cancer Prev, 11, 1731-9.

16.
Ferlay J, Shin HR, Bray F, et al (2013). Globocan 2008: cancer incidence and mortality worldwide: IARC cancerbase No. 10. Lyon, International Agency for Research on Cancer, 2010. globocan.iarc.fr.

17.
Fritz AG (2000). International classification of diseases for oncology: ICD-O World Health Organization.

18.
Grodski S, Brown T, Sidhu S, et al (2008). Increasing incidence of thyroid cancer is due to increased pathologic detection. Surg, 144, 1038-43. crossref(new window)

19.
Guay, B., Johnson-Obaseki, S., McDonald, J.T., Connell, C., & Corsten, M. (2014). Incidence of differentiated thyroid cancer by socioeconomic status and urban residence: Canada 1991-2006. Thyroid, 24, 552-555. crossref(new window)

20.
Ito Y, Miyauchi A, Kihara M, et al (2014). Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid, 24, 27-34. crossref(new window)

21.
Kent WD, Hall SF, Isotalo PA, Houlden RL, George RL, Groome PA (2007). Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. CMAJ, 177, 1357-61. crossref(new window)

22.
Kilfoy BA, Zheng T, Holford TR, et al (2009). International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control, 20, 525-31. crossref(new window)

23.
Kutikhin AG, Yuzhalin AE, Brailovskiy VV, et al (2012). Analysis of cancer incidence and mortality in the industrial region of South-East Siberia from 1991 through 2010. Asian Pac.J Cancer Prev, 13, 5189-93. crossref(new window)

24.
LiVolsi VA (2011). Papillary thyroid carcinoma: an update. Mod Pathol, 24, 1-9. crossref(new window)

25.
Malone, MK, Zagzag, J, Ogilvie, JB, Patel, KN, & Heller, KS (2014). Thyroid cancers detected by imaging are not necessarily small or early stage. Thyroid, 24, 314-8. crossref(new window)

26.
McLeod DS (2010). Current concepts and future directions in differentiated thyroid cancer. Clin Biochem Rev, 31, 9-19.

27.
McNally RJ, Blakey K, James PW, et al (2012). Increasing incidence of thyroid cancer in Great Britain, 1976-2005: age-period-cohort analysis. Eur J Epidemiol, 27, 615-22. crossref(new window)

28.
Minelli G, Conti S, Manno V, Olivieri A, Ascoli V (2013). The geographical pattern of thyroid cancer mortality between 1980 and 2009 in Italy. Thyroid, 23, 1609-18. crossref(new window)

29.
Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, Parkin M (2009). Cancer incidence in Tehran metropolis: the first report from the Tehran population-based cancer registry, 1998-2001. Arch Iran Med, 12, 15-23.

30.
Netea-Maier RT, Aben KK, Casparie MK, et al (2008). Trends in incidence and mortality of thyroid carcinoma in The Netherlands between 1989 and 2003: correlation with thyroid fine-needle aspiration cytology and thyroid surgery. Int J Cancer, 123, 1681-4. crossref(new window)

31.
Olaleye O, Ekrikpo U, Moorthy R, et al (2011). Increasing incidence of differentiated thyroid cancer in South East England: 1987-2006. Eur Arch Otorhinolaryngol, 268, 899-906. crossref(new window)

32.
Patel KN, Shaha AR (2006). Poorly differentiated and anaplastic thyroid cancer. Cancer Control, 13, 119-28.

33.
Pathak KA, Leslie WD, Klonisch TC, Nason RW (2013). The changing face of thyroid cancer in a population-based cohort. Cancer Med, 2, 537-44. crossref(new window)

34.
Reitzel LR, Nguyen N, Li N, et al (2014). Trends in thyroid cancer incidence in Texas from 1995 to 2008 by socioeconomic status and race/ethnicity. Thyroid, 24, 556-67. crossref(new window)

35.
Roche LM, Niu X, Pawlish KS, Henry KA (2011). Thyroid cancer incidence in New Jersey: time trend, birth cohort and socioeconomic status analysis (1979-2006). J Environ Public Health, 2011, 850105.

36.
Siu S, McDonald JT, Rajaraman M, et al (2014). Is lower socioeconomic status associated with more advanced thyroid cancer stage at presentation? a study in two Canadian centers. Thyroid, 24, 545-51. crossref(new window)

37.
Sprague BL, Warren AS, Trentham-Dietz A (2008). Thyroid cancer incidence and socioeconomic indicators of health care access. Cancer Causes Control, 19, 585-93. crossref(new window)

38.
Sriplung H, Sontipong S, Martin N, et al (2005). Cancer incidence in Thailand, 1995-1997. Asian Pac J Cancer Prev, 6, 276-81.

39.
Sungwalee W, Vatanasapt P, Kamsa-Ard S, Suwanrungruang K, Promthet S (2013). Reproductive risk factors for thyroid cancer: a prospective cohort study in Khon Kaen, Thailand. Asian Pac J Cancer Prev, 14, 5153-5. crossref(new window)

40.
Udelsman R, Zhang Y (2014). The epidemic of thyroid cancer in the United States: the role of endocrinologists and ultrasounds. Thyroid, 24, 472-9. crossref(new window)

41.
Veiga LH, Neta G, Aschebrook-Kilfoy B, Ron E, Devesa SS (2013). Thyroid cancer incidence patterns in Sao Paulo, Brazil, and the U.S. SEER program, 1997-2008. Thyroid, 23, 748-57. crossref(new window)

42.
Wartofsky L (2010). Increasing world incidence of thyroid cancer: increased detection or higher radiation exposure? Hormones, 9, 103-8. crossref(new window)